Patent · US Active

Processes for making ponatinib and intermediates thereof

US9493473B2 · kind B2 · utility

1Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 30, 2015
Grant dateNov 15, 2016
Priority date—
Expiry dateDec 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/48
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel synthetic approaches to make 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide, intermediates and pharmaceutically acceptable salts thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.